Tabula Rasa HealthCare - TRHC Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" TRHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRHC, but not buy additional shares or sell existing shares.
View TRHC analyst ratings or view top-rated stocks.

3 Wall Street analysts have issued 12 month price targets for Tabula Rasa HealthCare's shares. Their TRHC share price forecasts range from $5.00 to $6.00. On average, they predict the company's stock price to reach $5.50 in the next twelve months. This suggests a possible upside of 10.0% from the stock's current price.
View analysts price targets for TRHC or view top-rated stocks among Wall Street analysts.

Tabula Rasa HealthCare's stock was trading at $4.95 at the beginning of 2023. Since then, TRHC shares have increased by 1.0% and is now trading at $5.00.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our TRHC earnings forecast.

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) issued its quarterly earnings data on Thursday, November, 4th. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.19) by $0.15. The firm had revenue of $86.60 million for the quarter, compared to analysts' expectations of $88.54 million. Tabula Rasa HealthCare had a negative net margin of 49.25% and a negative trailing twelve-month return on equity of 472.90%. The business's revenue for the quarter was up 22.8% compared to the same quarter last year. During the same period last year, the company posted ($0.35) EPS.

Tabula Rasa HealthCare updated its first quarter 2023 earnings guidance on Monday, March, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $82.00 million-$84.00 million, compared to the consensus revenue estimate of $76.27 million.

24 employees have rated Tabula Rasa HealthCare Chief Executive Officer Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among the company's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), Boeing (BA), Salesforce (CRM), Intel (INTC) and Netflix (NFLX).

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

Tabula Rasa HealthCare's stock is owned by many different institutional and retail investors. Top institutional investors include UBS Group AG (4.80%), Fuller & Thaler Asset Management Inc. (1.30%), Millennium Management LLC (1.19%), Spears Abacus Advisors LLC (0.90%), Geode Capital Management LLC (0.87%) and Bank of Montreal Can (0.81%). Insiders that own company stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Indaba Capital Management, LP, Jan Berger, Michael Greenhalgh, Michael J Purcell, Orsula V Knowlton, Orsula V Knowlton, Samira Beckwith and Thomas Cancro.
View institutional ownership trends.

Shares of TRHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TRHC stock can currently be purchased for approximately $5.00.

Tabula Rasa HealthCare (NASDAQ:TRHC) has a market capitalization of $134.35 million and generates $299.52 million in revenue each year. The company earns $-147,510,000.00 in net income (profit) each year or ($6.09) on an earnings per share basis.

The company employs 1,027 workers across the globe.

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The official website for the company is www.tabularasahealthcare.com. The company can be reached via phone at (866) 648-2767 or via email at tabularasa@westwicke.com.